Preclinical Imaging Facility

At the Innovation Centre's world-class Preclinical Imaging Facility, non-invasive and in vivo techniques enable the study of animal models over time, which is crucial for observing changes to the organs, tissues, cells or molecules.

It is also essential for assessing the structure and function of the heart in conditions such as cardiomyopathy, congenital heart disease, heart failure and myocardial-infarction cardiac damage.

Scientists can study the processes that determine the health of a heart, and of the blood vessels that supply the heart with oxygen and nutrients, to discover how heart disease develops, and provide a means to monitor the effectiveness of new treatments.

Based at the Victor Chang Cardiac Research Institute, the Preclinical Imaging Facility features; 


The positron emission tomography (PET) and magnetic resonance imaging (MRI) PET-MRI scanner reveals disease progression and associated changes, allowing scientists to determine specific biological processes such as cell development, inflammation and the composition of atherosclerotic plaques.


Combining X-ray imaging with fluorescence imaging, the FLECT-CT scanner details anatomy and allows the detection of fluorescent molecules and cells.

Integrated with genetic, proteomic and metabolomic studies, this research provides a unique, mechanistic insight into cardiovascular disease, so that we can continue our search to solve the unsolved and find cures for heart diseases.

Funded by the NSW Government, The Preclinical Imaging Facility complements the Micro Imaging Facility, the Metabolomics Facility, the Stem Cell Facility and the Clinical Imaging Facility for a consolidated approach to cardiovascular health and disease.

Download Brochure


Dr Johanna Barclay
Innovation Centre Manager